Viemed Healthcare, Inc. (VMD)

Viemed Healthcare’s revenue came in essentially in line with consensus but EPS missed expectations in the second fiscal quarter of 2026, reported August 3, 2026. Revenue rose 23.9% to about $78.1 million (up from roughly $63.1 million a year ago), with the topline result in line as revenue of $78.1 million versus an estimate of $78.0 million (+0.1%, verdict: in line), while EPS of $0.07 trailed the $0.12 estimate (-41.7%, verdict: trailed) and was down from $0.08 a year ago. Profitability included gross profit of roughly $44.7 million with gross margin at 57.2%, and operating income of about $5.1 million for an operating margin of 6.5%. Net income declined 12.4% to around $2.8 million (from roughly $3.2 million a year ago). The company generated about $15.9 million of operating cash flow and repurchased roughly $5.3 million of stock during the quarter. Next-period consensus calls for EPS of $0.12 on revenue of $80.8 million.